Status:
COMPLETED
Steroids After Laser Trabeculoplasty for Glaucoma
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Bascom Palmer Eye Institute
University of Pittsburgh Medical Center
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocul...
Detailed Description
SLT is used to lower intraocular pressure in glaucoma, but it is not know whether the choice of eyedrops administered in the post-operative period affects SLT efficacy. Practitioners commonly use ster...
Eligibility Criteria
Inclusion
- clinical diagnosis of glaucoma
- clinician has determined that SLT laser is indicated
- IOP currently \>18 and was ever \>21 in the past (e.g. prior to treatment)
Exclusion
- prior history of uveitis
- prior glaucoma surgery including glaucoma laser surgery
- pregnant or 3 months post-partum
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00981435
Start Date
September 1 2009
End Date
September 1 2015
Last Update
August 7 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bascom Palmer Eye Institute
Miami, Florida, United States, 33136
2
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213